Medicover AB Statistics

Total Valuation

Medicover AB has a market cap or net worth of EUR 3.70 billion. The enterprise value is 5.05 billion.

Market Cap	3.70B
Enterprise Value	5.05B

Important Dates

The last earnings date was Thursday, July 24, 2025.

Earnings Date	Jul 24, 2025
Ex-Dividend Date	Apr 30, 2025

Share Statistics

Current Share Class	74.36M
Shares Outstanding	n/a
Shares Change (YoY)	+0.40%
Shares Change (QoQ)	-0.00%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	50.84M

Valuation Ratios

The trailing PE ratio is 85.30 and the forward PE ratio is 40.51.

PE Ratio	85.30
Forward PE	40.51
PS Ratio	1.64
PB Ratio	7.63
P/TBV Ratio	n/a
P/FCF Ratio	23.53
P/OCF Ratio	13.16
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 16.78, with an EV/FCF ratio of 32.12.

EV / Earnings	116.43
EV / Sales	2.24
EV / EBITDA	16.78
EV / EBIT	45.63
EV / FCF	32.12

Financial Position

The company has a current ratio of 0.87, with a Debt / Equity ratio of 2.94.

Current Ratio	0.87
Quick Ratio	0.77
Debt / Equity	2.94
Debt / EBITDA	4.73
Debt / FCF	9.05
Interest Coverage	1.73

Financial Efficiency

Return on equity (ROE) is 7.68% and return on invested capital (ROIC) is 3.87%.

Return on Equity (ROE)	7.68%
Return on Assets (ROA)	3.17%
Return on Invested Capital (ROIC)	3.87%
Return on Capital Employed (ROCE)	6.24%
Revenue Per Employee	48,051
Profits Per Employee	923
Employee Count	47,256
Asset Turnover	1.04
Inventory Turnover	28.02

Taxes

In the past 12 months, Medicover AB has paid 15.40 million in taxes.

Income Tax	15.40M
Effective Tax Rate	28.31%

Stock Price Statistics

The stock price has increased by +50.32% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+50.32%
50-Day Moving Average	22.86
200-Day Moving Average	19.17
Relative Strength Index (RSI)	57.16
Average Volume (20 Days)	41

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Medicover AB had revenue of EUR 2.26 billion and earned 43.40 million in profits. Earnings per share was 0.29.

Revenue	2.26B
Gross Profit	508.60M
Operating Income	110.60M
Pretax Income	54.40M
Net Income	43.40M
EBITDA	210.60M
EBIT	110.60M
Earnings Per Share (EPS)	0.29

Full Income Statement

Balance Sheet

The company has 89.40 million in cash and 1.42 billion in debt, giving a net cash position of -1.33 billion.

Cash & Cash Equivalents	89.40M
Total Debt	1.42B
Net Cash	-1.33B
Net Cash Per Share	n/a
Equity (Book Value)	485.00M
Book Value Per Share	3.10
Working Capital	-68.70M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 281.30 million and capital expenditures -124.00 million, giving a free cash flow of 157.30 million.

Operating Cash Flow	281.30M
Capital Expenditures	-124.00M
Free Cash Flow	157.30M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 22.52%, with operating and profit margins of 4.90% and 1.92%.

Gross Margin	22.52%
Operating Margin	4.90%
Pretax Margin	2.41%
Profit Margin	1.92%
EBITDA Margin	9.33%
EBIT Margin	4.90%
FCF Margin	6.97%

Dividends & Yields

This stock pays an annual dividend of 0.15, which amounts to a dividend yield of 0.63%.

Dividend Per Share	0.15
Dividend Yield	0.63%
Dividend Growth (YoY)	25.00%
Years of Dividend Growth	n/a
Payout Ratio	51.84%
Buyback Yield	-0.40%
Shareholder Yield	0.23%
Earnings Yield	1.17%
FCF Yield	4.25%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Medicover AB has an Altman Z-Score of 2.03 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.03
Piotroski F-Score	7